Page last updated: 2024-12-06

valofane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

valofane: neurotropic drug; RN given refers to cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71122
CHEMBL ID2104479
SCHEMBL ID715189
MeSH IDM0040226

Synonyms (30)

Synonym
valofan
2-allophanoyl-2-allyl-4-pentanolid
valofane
alpha-allophanoyl-alpha-allyl-gamma-valerolacton
ureid kwasu 4-allilo-2-metylo-tetrahydro-furan-5-on-4-karboksylowego [polish]
3-furancarboxamide, n-(aminocarbonyl)tetrahydro-5-methyl-2-oxo-3-(2-propenyl)-
(3-allyltetrahydro-5-methyl-2-oxo-3-furoyl)urea
malonamic acid, 2-allyl-n-carbamoyl-2-(2-hydroxypropyl)-, gamma-lactone
hh 10018
valofane [inn]
ureide of 4-allyl-2-methyltetrahydrofuran-5-one-4-carboxylic acid
urea, (3-allyltetrahydro-5-methyl-2-oxo-3-furoyl)-
einecs 221-857-9
brn 1431729
valofanum [latin]
valofano [spanish]
n-carbamoyl-5-methyl-2-oxo-3-prop-2-enyloxolane-3-carboxamide
3258-51-3
valofanum
unii-x71n6e5ipo
ureid kwasu 4-allilo-2-metylo-tetrahydro-furan-5-on-4-karboksylowego
valofano
5-18-08-00081 (beilstein handbook reference)
x71n6e5ipo ,
CHEMBL2104479
SCHEMBL715189
2-allophanyl-2-allyl-gamma-valerolactone
Q7912521
DTXSID20863139
AKOS040747568

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The distribution and kinetics of the two compounds appeared to obey a single compartment system with a half-life of approximately one hour."( Pharmacokinetics of 14C-2-allophanyl-2-allyl -gamma-valero-lactone: a prodrug of proxibarbal in rats.
Compagnon, PL; Jacquot, C; Lambrey, B, 1981
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]